BioGeneration Ventures (BGV) is a venture capital company with a focus on early stage European biotech, medtech, and diagnostics companies. BGV has a strong track record of significant financial returns through investing in innovations in healthcare and providing the expertise to build world-class teams.
The Company manages over €100 million of funds investing in areas where true scientific innovations, the unmet medical need, and the potential to demonstrate a significant proof of concept all come together.
We spoke with BGV General Partner, Eric Benhamou, to find out more. Don't miss this one! Listen below: